AXA SA (AXA.DE) Stock Fundamental Analysis
FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR
Overall AXA gets a fundamental rating of 5 out of 10. We evaluated AXA against 40 industry peers in the Insurance industry. AXA has only an average score on both its financial health and profitability. AXA is not valued too expensively and it also shows a decent growth rate. Finally AXA also has an excellent dividend rating. This makes AXA very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
AXA had positive earnings in the past year.
In the past year AXA had a positive cash flow from operations.
Each year in the past 5 years AXA has been profitable.
AXA had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of AXA (1.18%) is comparable to the rest of the industry.
AXA has a Return On Equity of 15.39%. This is in the better half of the industry: AXA outperforms 67.50% of its industry peers.
The Return On Invested Capital of AXA (1.33%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for AXA is in line with the industry average of 2.04%.
The 3 year average ROIC (1.29%) for AXA is below the current ROIC(1.33%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROIC | 1.33% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
1.3 Margins
AXA has a Profit Margin of 8.80%. This is comparable to the rest of the industry: AXA outperforms 50.00% of its industry peers.
AXA's Profit Margin has improved in the last couple of years.
With a Operating Margin value of 12.32%, AXA perfoms like the industry average, outperforming 55.00% of the companies in the same industry.
In the last couple of years the Operating Margin of AXA has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A |
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXA is destroying value.
The number of shares outstanding for AXA has been reduced compared to 1 year ago.
AXA has less shares outstanding than it did 5 years ago.
AXA has a worse debt/assets ratio than last year.
2.2 Solvency
AXA has an Altman-Z score of 0.36. This is a bad value and indicates that AXA is not financially healthy and even has some risk of bankruptcy.
AXA's Altman-Z score of 0.36 is amongst the best of the industry. AXA outperforms 90.00% of its industry peers.
The Debt to FCF ratio of AXA is 2.19, which is a good value as it means it would take AXA, 2.19 years of fcf income to pay off all of its debts.
AXA has a better Debt to FCF ratio (2.19) than 72.50% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that AXA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.53, AXA is in the better half of the industry, outperforming 65.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Altman-Z | 0.36 |
ROIC/WACC0.13
WACC10.43%
2.3 Liquidity
A Current Ratio of 0.87 indicates that AXA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.87, AXA belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
AXA has a Quick Ratio of 0.87. This is a bad value and indicates that AXA is not financially healthy enough and could expect problems in meeting its short term obligations.
AXA has a better Quick ratio (0.87) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 12.08% over the past year.
Measured over the past years, AXA shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.09% on average per year.
Looking at the last year, AXA shows a small growth in Revenue. The Revenue has grown by 4.38% in the last year.
AXA shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.16% yearly.
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
3.2 Future
AXA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.12% yearly.
AXA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.15% yearly.
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
AXA is valuated reasonably with a Price/Earnings ratio of 11.68.
72.50% of the companies in the same industry are more expensive than AXA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of AXA to the average of the S&P500 Index (27.15), we can say AXA is valued rather cheaply.
A Price/Forward Earnings ratio of 10.47 indicates a reasonable valuation of AXA.
AXA's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.60. AXA is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.68 | ||
| Fwd PE | 10.47 |
4.2 Price Multiples
AXA's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. AXA is cheaper than 65.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.75 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
AXA has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.01
PEG (5Y)0.65
EPS Next 2Y9.13%
EPS Next 3Y8.44%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 5.17%, AXA is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 4.58, AXA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.42, AXA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.17% |
5.2 History
The dividend of AXA is nicely growing with an annual growth rate of 8.12%!
Dividend Growth(5Y)8.12%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
57.97% of the earnings are spent on dividend by AXA. This is a bit on the high side, but may be sustainable.
AXA's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP57.97%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
FRA:AXA (6/27/2025, 7:00:00 PM)
41.94
+0.31 (+0.74%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners33.99%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap92.90B
Analysts81.48
Price Target43.85 (4.55%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.17% |
Yearly Dividend2.02
Dividend Growth(5Y)8.12%
DP57.97%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.24%
PT rev (3m)6.1%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-0.58%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.68 | ||
| Fwd PE | 10.47 | ||
| P/S | 1.06 | ||
| P/FCF | 7.75 | ||
| P/OCF | 7.45 | ||
| P/B | 1.86 | ||
| P/tB | 3.39 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.59
EY8.56%
EPS(NY)4.01
Fwd EY9.55%
FCF(TTM)5.41
FCFY12.91%
OCF(TTM)5.63
OCFY13.42%
SpS39.43
BVpS22.55
TBVpS12.36
PEG (NY)1.01
PEG (5Y)0.65
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 15.39% | ||
| ROCE | 1.67% | ||
| ROIC | 1.33% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 12.32% | ||
| PM (TTM) | 8.8% | ||
| GM | N/A | ||
| FCFM | 13.73% |
ROA(3y)1.09%
ROA(5y)0.91%
ROE(3y)14.54%
ROE(5y)11.55%
ROIC(3y)1.29%
ROIC(5y)1.11%
ROICexc(3y)1.34%
ROICexc(5y)1.16%
ROICexgc(3y)1.75%
ROICexgc(5y)1.48%
ROCE(3y)1.62%
ROCE(5y)1.41%
ROICexcg growth 3Y10.47%
ROICexcg growth 5Y16.55%
ROICexc growth 3Y8.69%
ROICexc growth 5Y14.36%
OM growth 3Y15.12%
OM growth 5Y20.23%
PM growth 3Y14.87%
PM growth 5Y26.69%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.13
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 2.19 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.54% | ||
| Interest Coverage | 1.72 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 156.03% | ||
| Current Ratio | 0.87 | ||
| Quick Ratio | 0.87 | ||
| Altman-Z | 0.36 |
F-Score7
WACC10.43%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.46%
Cap/Sales(5y)0.4%
Profit Quality(3y)104.89%
Profit Quality(5y)238.88%
High Growth Momentum
Growth
EPS 1Y (TTM)12.08%
EPS 3Y9.29%
EPS 5Y18.09%
EPS Q2Q%18.49%
EPS Next Y11.56%
EPS Next 2Y9.13%
EPS Next 3Y8.44%
EPS Next 5Y5.12%
Revenue 1Y (TTM)4.38%
Revenue growth 3Y-10.62%
Revenue growth 5Y-8.16%
Sales Q2Q%-6.94%
Revenue Next Year6.29%
Revenue Next 2Y5.45%
Revenue Next 3Y2.6%
Revenue Next 5Y7.15%
EBIT growth 1Y18.59%
EBIT growth 3Y2.9%
EBIT growth 5Y10.41%
EBIT Next Year25.76%
EBIT Next 3Y11.02%
EBIT Next 5YN/A
FCF growth 1Y240.94%
FCF growth 3Y7.74%
FCF growth 5Y9.94%
OCF growth 1Y216.74%
OCF growth 3Y7.85%
OCF growth 5Y9.48%